Prelude Capital Management’s Medidata Solutions, Inc. MDSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-184,272
Closed -$16.9M 2438
2019
Q3
$16.9M Buy
184,272
+163,924
+806% +$15M 0.76% 13
2019
Q2
$1.84M Buy
+20,348
New +$1.79M 0.09% 211
2018
Q3
Sell
-3,759
Closed -$303K 2192
2018
Q2
$303K Hold
3,759
0.02% 667
2018
Q1
$236K Buy
3,759
+380
+11% +$25.3K 0.02% 646
2017
Q4
$214K Buy
3,379
+976
+41% +$69.5K 0.02% 593
2017
Q3
$188K Sell
2,403
-400
-14% -$30.5K 0.02% 676
2017
Q2
$219K Buy
+2,803
New +$195K 0.02% 546
2016
Q1
Sell
-53
Closed -$3K 1654
2015
Q4
$3K Buy
+53
New +$2.33K ﹤0.01% 1388
2014
Q4
Sell
-6,325
Closed -$280K 2274
2014
Q3
$280K Buy
+6,325
New +$280K 0.04% 583

Other funds holding MDSO

Prelude Capital Management's MDSO Position: Q4 2019 in Review

Prelude Capital Management sold out of Medidata Solutions, Inc. (MDSO) in Q4 2019, closing a stake of 184,272 shares — an estimated $16.9M sold.

Prelude Capital Management first reported a position in MDSO in Q3 2014 and held it in 9 quarters. The position peaked at $16.9M in Q3 2019. 1 fund tracked by Wall St. Rank holds MDSO as of Q4 2019.

  • Prelude Capital Management reported no remaining Medidata Solutions, Inc. position as of Q4 2019 after selling out during the quarter.
  • Prelude Capital Management sold 184,272 Medidata Solutions, Inc. shares in Q4 2019, an estimated $16.9M.
  • Prelude Capital Management first reported a position in Medidata Solutions, Inc. in Q3 2014 and held it in 9 quarters.
  • Prelude Capital Management's Medidata Solutions, Inc. position peaked at $16.9M in Q3 2019.
  • 1 fund tracked by Wall St. Rank held Medidata Solutions, Inc. as of Q4 2019.

Based on Prelude Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.